Friendly takeover offer for Patheon values contract drug maker at US$1.4 billion + MORE Nov 19th

TSX getting you down? There are always sound investment alternatives.
Latest News
 canadian savings bond

Drowning in debt is the new normal in Canada + MORE Apr 24th

The Canadian Press/Ryan Remiorz On any given day now you can expect to hear at least one economist, public official or financial commentator express grave concern about the mountain of debt Canadians now carry. The bloated debt loads of Canadian households has become a pervasive topic in media. B.... More »

Seven reasons SmartREIT makes for a wise investment + MORE Aug 3rd

Its attractive yield combined with potential modest unit price appreciation is ideal in this sluggish Canadian economy .... More »
 real estate

The best RBC credit cards in Canada for 2024 + MORE Jul 2nd

Credit Cards The best RBC credit cards in Canada for 2024 Discover the best RBC credit cards, whether you’re looking for cash back, travel points or low interest. Compare now Why trust us MoneySense i.... More »

The best GIC rates in Canada for 2024 + MORE Jun 26th

Investing The best GIC rates in Canada Find the best GIC rates in Canada. Plus, everything you need to know about how they work. Compare highest rates Why trust us MoneySense is an award-winning.... More »

Microsoft Teams passes 20 million daily users, up more than half in 4 months - VentureBeat Nov 20th

Microsoft Teams passes 20 million daily users, up more than half in 4 months  VentureBeatMicrosoft Teams surpasses 20 million daily active users, up 50% from July  Financial PostSlack stock drops as Microsoft claims big lead with 20 million Teams users  CNBCSlack plunge.... More »
TORONTO – Patheon Inc. (TSX:PTI) has received a friendly going-private proposal that values the TSX-listed company at about US$1.4 billion, more than 50 per cent above its recent market price.
The offer of US$9.32 per share cash for minority shareholders is coming from a group backed by Patheon’s largest shareholder, U.S. private equity firm JLL Partners.
JLL and European life sciences company Royal DSM plan to combine Patheon into a new global contract drug manufacturer with 23 locations around the world and 8,300 employees.
The new company will be owned 51 per cent by JLL and 49 per cent by Royal DSM.
JLL Partners currently owns about 55.7 per cent of Patheon’s equity.
As a result, the takeover offer would cost about US$582 million cash to buy out shareholders other than JLL and its affiliates.
Patheon shares closed Monday at C$5.94 at the Toronto Stock Exchange, giving it a market value of C$837 million at the time.
The post Friendly takeover offer for Patheon values contract drug maker at US$1…

Continue Reading On canadianbusiness.com »

With traditional assets looking scary, investors are piling into fine art – and breaking sales records

Continue Reading On theglobeandmail.com »

Bay TodayBusy day for MPs studying federal budget, Canada-EU trade agreementMontreal GazetteOTTAWA – Members of Parliament will be busy today at committees dealing with the economy and trade. Citizenship and Immigration Minister Chris Alexander appears before a Commons committee hearing witnesses on Bill C-4, the Budget Implementation …Ottawa agenda for Monday: Parliament returns, economy, investment and healthWinnipeg Free Pressall 18 news articles »

Continue Reading On Montrealgazette.com »

5.5 year – 3.00%

– ratesupermarket.ca

This GIC rate is offered by Outlook Financial and was updated on 2013-10-30. Click on the link above to get more details or apply online.

Continue Reading On ratesupermarket.ca »

The virtual currency known as Bitcoin took a step away from the margins of the financial system Monday, as the U.S. Senate homeland security and governmental affairs committee set aside a good chunk of the afternoon for testimony on whether the …

Continue Reading On theglobeandmail.com »

Share

PinIt
Compare insurance quotes through Kanetix.ca - save time and money!